Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inmaculada Hernandez

Showing results (101-110 of 183) with videos related to

Pageof 19
Sort By:
JAMA Internal Medicine|February 19, 2019
Assessment of Price Changes of Existing Tumor Necrosis Factor Inhibitors After the Market Entry of CompetitorsAlvaro San-Juan-Rodriguez, Max V Prokopovich, William H Shrank, et al.
JAMA Network Open|March 13, 2025
Vulnerability Index Approach to Identify Pharmacy Deserts and Keystone PharmaciesWalter S Mathis, Lucas A Berenbrok, Peter A Kahn, et al.
The Plant Journal : for Cell and Molecular Biology|April 3, 2007
SDE5, the putative homologue of a human mRNA export factor, is required for transgene silencing and accumulation of trans-acting endogenous siRNAInmaculada Hernandez-Pinzon, Nataliya E Yelina, Frank Schwach, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 12, 2019
Impact of Star Rating Medication Adherence Measures on Adherence for Targeted and Nontargeted MedicationsNatasha Parekh, Kiraat D Munshi, Inmaculada Hernandez, et al.
JAMA|March 24, 2025
Projected Out-of-Pocket Savings of the Medicare Part D $2 Drug List ModelInmaculada Hernandez, Nico Gabriel, Yuvraj Pathak, et al.
JAMA|December 2, 2024
Drug Prices Negotiated by Medicare vs US Net Prices and Prices in Other CountriesOlivier J Wouters, Sean D Sullivan, Emma M Cousin, et al.
The American Journal of Managed Care|July 19, 2019
Number of manufacturers and generic drug pricing from 2005 to 2017Inmaculada Hernandez, Chester B Good, Walid F Gellad, et al.
Neurology. Clinical Practice|February 19, 2026
Changes in List and Net Prices for Multiple Sclerosis Disease-Modifying Therapy, 2013 to 2021Daniel M Hartung, Nico Gabriel, Walid F Gellad, et al.
Journal of Managed Care & Specialty Pharmacy|December 30, 2020
Trends in list prices, net prices, and discounts of self-administered injectable tumor necrosis factor inhibitorsAlvaro San-Juan-Rodriguez, Vincent M Piro, Chester B Good, et al.
JAMA Network Open|August 4, 2023
Association Between Redlining and Spatial Access to PharmaciesGiovanni Appolon, Shangbin Tang, Nico Gabriel, et al.
Pageof 19

Showing results (101-110 of 183) with videos related to

Sort By:
Pageof 19
JAMA Internal Medicine|February 19, 2019
Assessment of Price Changes of Existing Tumor Necrosis Factor Inhibitors After the Market Entry of CompetitorsAlvaro San-Juan-Rodriguez, Max V Prokopovich, William H Shrank, et al.
JAMA Network Open|March 13, 2025
Vulnerability Index Approach to Identify Pharmacy Deserts and Keystone PharmaciesWalter S Mathis, Lucas A Berenbrok, Peter A Kahn, et al.
The Plant Journal : for Cell and Molecular Biology|April 3, 2007
SDE5, the putative homologue of a human mRNA export factor, is required for transgene silencing and accumulation of trans-acting endogenous siRNAInmaculada Hernandez-Pinzon, Nataliya E Yelina, Frank Schwach, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 12, 2019
Impact of Star Rating Medication Adherence Measures on Adherence for Targeted and Nontargeted MedicationsNatasha Parekh, Kiraat D Munshi, Inmaculada Hernandez, et al.
JAMA|March 24, 2025
Projected Out-of-Pocket Savings of the Medicare Part D $2 Drug List ModelInmaculada Hernandez, Nico Gabriel, Yuvraj Pathak, et al.
JAMA|December 2, 2024
Drug Prices Negotiated by Medicare vs US Net Prices and Prices in Other CountriesOlivier J Wouters, Sean D Sullivan, Emma M Cousin, et al.
The American Journal of Managed Care|July 19, 2019
Number of manufacturers and generic drug pricing from 2005 to 2017Inmaculada Hernandez, Chester B Good, Walid F Gellad, et al.
Neurology. Clinical Practice|February 19, 2026
Changes in List and Net Prices for Multiple Sclerosis Disease-Modifying Therapy, 2013 to 2021Daniel M Hartung, Nico Gabriel, Walid F Gellad, et al.
Journal of Managed Care & Specialty Pharmacy|December 30, 2020
Trends in list prices, net prices, and discounts of self-administered injectable tumor necrosis factor inhibitorsAlvaro San-Juan-Rodriguez, Vincent M Piro, Chester B Good, et al.
JAMA Network Open|August 4, 2023
Association Between Redlining and Spatial Access to PharmaciesGiovanni Appolon, Shangbin Tang, Nico Gabriel, et al.
Pageof 19